OR WAIT null SECS
April 14, 2015
The single-use clarification system eliminates centrigues; harvesting can be performed in one step; and process robustness and predictability are ensured.
April 02, 2015
NIH announced positive safety results from the vaccine, VSV-ZEBOV, and found that all patients in the study experienced a strong antibody response.
The Human Microbiome Project has increased our understanding of the relationship between humans and microorganisms. The authors offer a new perspective on how this knowledge should be considered in setting standards for pharmaceutical quality control in microbiology.
In this article, industry experts discuss critical analyses for demonstrating biosimilarity.
FDA approves a biosimilar and loses a commissioner in March.
Multivariate data analysis (MVDA) is being used to effectively handle complex datasets generated by process analytical technology (PAT) in biopharmaceutical process development and manufacturing.
March 31, 2015
Merck Serono announces that it will work with Intrexon to develop a cancer therapy using chimeric antigen receptor T-cells.
March 30, 2015
Rentschler Biotechnologie launches 2000-L single-use bioreactor and announces additional expansion.
Biosimilar applicants will not be required to hand over their biosimilar applications and manufacturing dossiers to innovator companies, determines FDA.
March 24, 2015
Clinical trial results suggest that monoclonal antibodies targeting the function of proinflammatory cytokine IL-17A in psoriasis may be significantly superior to other treatments.